Skip to main content

Improved quality outcomesMerchant et al., (2018). Impact of a Digital Health Intervention on Asthma Resource Utilization. WAOJ,Alshabani et al., (2019). J. Electronic Inhaler Monitoring and Healthcare Utilization in Chronic Obstructive Pulmonary Disease. Telemedicine and Telecare and increased care team efficiency

Propeller helps you proactively identify patients at increased risk of exacerbations, enabling timely interventions.

The FDA-cleared Propeller Digital Therapeutic Platform supports hospitals and health systems where it matters most.

Mother with daughter looking into phone

The FDA-cleared Propeller Digital Therapeutic Platform supports hospitals and health systems where it matters most.

Our platform surrounds patients to power sustainable behavior change

Deliver personalized care to motivate and engage patients, empower them to sustain healthy habits, and fulfill their expectations for more digital care options

An intentional clinician experience removes costly friction points

Leverage clinical decision support within your native workflow, streamline care coordination, and proactively intervene with at-risk patients

We deliver proven clinical outcomes, including in underserved populations

Improve quality metrics across the board, increase patient adherence, and reduce costly exacerbations

Propeller lowers the total cost of care in both value-based and fee-for-service models

Reduce unnecessary acute resource utilization, transform chronic condition management, and deliver the right treatment at the right location and time

 

Female doctor looking at her work computer in her office

For more than a decade, Propeller has supported 80+ member and patient programs. Our digital health platform has delivered:

0%

Improved medication adherence

0%

Less asthma-related rescue use

Propeller Digital Therapeutic Platform

Girl with her dog

PropellerConnect™
Sensors & Data Connectivity

Propeller’s FDA-cleared and CE-marked sensors attach to a patient’s inhaler and passively record medication use. Bluetooth or cellular connectivity transmits data to Propeller’s cloud for aggregation, analysis, and sharing.

MyPropeller™
Patient App & Portal

Sensor data is sent to the Propeller mobile app or online portal, empowering patients to learn about their breathing and triggers while delivering personalized, motivating journeys that build healthy habits.

PropellerInsight™
Clinical Decision Support & Analytics

Via an EHR integration or our Clinician Portal, monitor your patients’ medication use and control status while gaining a clearer understanding of their symptoms and triggers.

PropellerCare™
Support and Coaching

Our patient success team ensures users receive personalized support and coaching to help them confidently navigate the platform, stay focused on their goals, and take control of their breathing.

Male doctor holding an inhaler with Propeller sensor and a female patient looking at the Propeller app on her phone

Remote Monitoring Solution

Propeller enables independent physician groups to enhance patient care through Remote Therapeutic Monitoring (RTM) programs for eligible chronic patients.

 

Our solution for RTM programs consists of an inhaler sensor/cellular hub to capture patient medication use data, an optional patient mobile app and web portal for patient self-education and engagement, and a web-based clinician portal for care teams to access and use patient data to help make informed treatment decisions.

Learn More
Doctor entering patient information on a computer

EHR Integrations

Patient data integrates with clinical teams & EHRs to inform treatment adjustments and prevent costly exacerbations — all within your native workflow.

 

We have integrations with Cerner® as part of the Cerner® code app gallery and with Epic® through a Redox integration. With EHR integration, you can enroll a patient in just two minutes.

Learn More

Featured Resources

Chronic respiratory patients prefer seeking environmental information from mobile apps

Environmental factors, such as air pollution and pollen levels, are influences known to significantly impact overall health. For patients with chronic respiratory conditions, these environmental factors can be triggers that mark the difference between a symptom-free day and an emergency room visit.1,2 However, despite their known health impacts, little research had been done to understand how people with chronic respiratory disease perceive and seek information regarding environmental risks – until now.

A study recently published in Frontiers in Digital Health – one of the first digital health studies to survey and evaluate patient perceptions of environmental influences – demonstrated that a majority of patients with asthma and COPD believe that a handful of specific environmental factors may make their symptoms worse. 

An analysis of survey responses collected from nearly 700 participants, all of whom use Propeller’s precision digital health platform to manage their chronic respiratory conditions, showed that pollen, mold, second-hand smoke and air pollution were the leading environmental factors perceived by users to worsen their symptoms. 

The Promise of Digital Health: Then, Now, and the Future

From the increased development of personalized therapeutics to the growing adoption of telemedicine, digital innovation has been applied to nearly every aspect of patient care and human health.

In a special publication with the National Academy of Medicine, Propeller Health and ResMed’s VP of Population Health Research, Meredith Barrett – alongside several luminaries in healthcare such as leaders from UCSF, Blue Shield of California, The Scripps Research Institute, and more – provides a comprehensive review of digital health solutions and identifies critical implementation opportunities including: 

The majority of patients find remote care helpful. Clinicians can benefit from patient use, too.

More and more patients with chronic conditions like asthma have adopted remote care and digital health tools to self-manage their conditions since the start of the COVID-19 pandemic. Survey results from a recent Propeller Health study to be presented at the 2022 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting found that the majority of patients (68.7%) find their use of remote care helpful. Of the 441 patients surveyed, about one third of patients reported that they connected with their asthma providers through video visits and messaging services.

This uptake in digital therapeutic and remote care adoption by patients has potentially significant benefits for clinicians as well. 

Contact us to learn more about Propeller for your practice